The European Commission will support Ventinova to bring FCV® into the ICU

The European Commission will support us to bring FCV® into the ICU in order to improve ventilation of ICU patients, including COVID-19 patients. With this significant financial grant of 2.5 M€, we are able to further improve our ventilator and to investigate and demonstrate clinical benefits of FCV® in ICU patients.
Ventinova aims to provide highly efficient and harmless respiration for all ventilated patients, including COVID-19 patients, to reduce mortality and hospital stay. We thank the European Innovation Counsel (EIC) for receiving the EIC Accelerator funding through the Horizon 2020 Framework Programme for Research and Innovation.